Large-scale testing (Phase 3)Study completedNCT00656136
What this trial is testing
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 585